Tag: Business
Sutter Health CEO Donates to Harris in Wake of Antitrust Investigation
Sutter Health's CEO, Warner Thomas, recently made significant donations to Vice President Harris' presidential campaign and the Democratic National Committee. Despite Harris' involvement in an antitrust investigation against Sutter Health in the past, Thomas...
Biotech News Roundup: Stay Updated on the Latest Developments in the Industry
Good morning, everyone! Today, we have some interesting updates from the biotech industry. The BIOSECURE Act is facing a crucial moment as it needs to be passed by Congress by December to avoid obstacles,...
AI Drug Development Company Recursion Cuts Jobs Post Exscientia Merger
Recursion Pharmaceuticals, a company known for its innovative use of artificial intelligence and machine learning in drug development, recently made the decision to lay off employees following a merger with Exscientia. This move comes...
The Main Target and Focus: The article focuses on key figures attending the J.P....
Highlights from J.P. Morgan Healthcare Conference Day 2 The J.P. Morgan Healthcare Conference on Day 2 saw a flurry of activity, with key industry figures making headlines and sharing insights that could shape the future...
Biotech Analyst and CEO Discuss Election Results: Insights from Brian Skorney and Daphne Zohar
Biotech analyst Brian Skorney and biotech executive Daphne Zohar recently appeared on "The Readout LOUD" podcast to share their thoughts on how the outcomes of the recent election may impact the biotech industry. They...
Pfizer’s New R&D Head, VC Deep-Dive, and FDA Commissioner: What You Need to Know
Pfizer has welcomed a new R&D head, Chris Boshoff, who is expected to make significant strides in research and development to satisfy investors. Additionally, the biotech venture capital landscape is set to see some...
RFK Jr. Considered for Health Secretary as Pharma Execs Seek Stability
Robert F. Kennedy Jr., a well-known critic of the pharmaceutical industry, has been considered for the position of Health Secretary. He has been vocal about his views on how the industry has influenced U.S....
Pharmalittle: GSK Leaves BIO, AbbVie Schizophrenia Drug Fails & More – Pharma News Update
Good morning, everyone, and welcome to a new week of work. We hope you had a restful weekend and are ready to dive back into the routine of online meetings and deadlines. Let's start...
Medicare Obesity Drug Coverage and 340B Analysis: Pharmalittle Updates
Good day, everyone! We hope you are all well despite the rainy weather. Remember, each day is a gift waiting to be unwrapped. As we take a short break for the upcoming holiday, let's...
Pharmacies Sue GoodRx and PBMs for Illegal Reimbursement Fees
Three independent pharmacies recently took legal action against GoodRx, a company that offers a prescription drug discount card, as well as several pharmacy benefit managers (PBMs). These lawsuits allege that GoodRx and the PBMs...
Unveiling JPM Day 1: A Comprehensive Overview for Investors
Unveiling JPM Day 1: A Comprehensive Overview for Investors Welcome to STAT’s exclusive coverage of the much-anticipated “JPM Week” in San Francisco, where the biotech world is abuzz with groundbreaking news, insightful analysis, and juicy...
Merck Expands Portfolio with Licensing of Chinese Cancer Drug
Merck, a leading pharmaceutical company, has recently taken a strategic step to enhance its cancer drug portfolio by acquiring the licensing rights for a new cancer drug from LaNova Medicines, a Chinese firm based...

















